Skip to main content



Local Cdiff information for Missouri

Missouri

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Missouri.



Local Cdiff information for Missouri

Missouri

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Missouri.

Providers

Dr. Jason G. Newland MD, MEd

Associate Professor of Pediatrics
St. Louis Children’s Hospital
1 Childrens Place
St. Louis, 63110
314-454-6050
FMT Provider: No
VISIT WEBSITE >

Dr. Wilfred Lee, MD

Cape Gastroenterology Specialists
28 S Mount Auburn Road
Cape Girardeau, 63701
(573) 331-3350
FMT Provider: Yes
VISIT WEBSITE >

Dr. Erik R. Dubberke, MD, MSPH

Associate Professor, Medicine, Division of Infectious Diseases
Washington University Infectious Diseases
620 S Taylor Ave
St. Louis, 63110
(314) 747-1206
EMAIL DR. DUBBERKE >
FMT Provider: Yes
VISIT WEBSITE >

Regulation

C. diff Infections

Total Reported Cases: 1831
Hospital Onset: 1831
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.77
CDC STATE PROGRESS REPORT >
STATE REPORTING >

Available Reports

Annual Progress based on SIR: 0.77
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: No
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available
STATUTE >

State Contact

Eric Hueste, Chief
Missouri Department of Health and Senior Services
930 Wildwood Drive
Jefferson City, 65102
573-751-6113
573-526-0235
EMAIL ERIC HUESTE, CHIEF >

CLINICAL TRIALS

Animal-Assisted Visitation Program Chlorhexidine Trial

Official Title: Clinical Trial of a Disinfectant Intervention in Therapy Dogs to Combat Hospital-associated Pathogens and Promote Sustainability of Animal-Assisted Visitation Programs
Trial No. NCT04171817
Type: Interventional
Recruitment: Recruiting
Sponsor: Johns Hopkins Bloomberg School of Public Health
Contact: Meghan F Davis, DVM PhD
EMAIL
Gender: All
Age: 2 Years to 17 Years

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older

To Understand the Safety and Effects of a C. Difficile Vaccine

Official Title: A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, Immunogenicity, and Immunopersistence of a Clostridioides Difficile Vaccine
Trial No. NCT05805826
Type: Interventional
Recruitment: Recruiting
Sponsor: Pfizer
Contact: Pfizer CT.gov Call Center
EMAIL >
Gender: All
Age: 65 Years and older

C.Difficile Observational Study

Official Title: An Observational Study in Adults With Clostridioides Difficile Infection to Determine the Feasibility and Logistics of Biospecimen Collection, Transportation and Testing at Select US Study Sites
Trial No. NCT06277999
Type: Observational
Recruitment: Recruiting
Sponsor: AstraZeneca
Contact: AstraZeneca Clinical Study Information Center
EMAIL >
Gender: All
Age: 18 Years and older